TReating Children to Prevent Exacerbations of Asthma (TREXA)

Background

Since asthma is the most common chronic childhood disease in the U.S., the CARE Network was established to evaluate treatments for children with asthma. The Childhood Asthma Research and Education (CARE) Network was established in 1999 by the National Heart, Lung and Blood Institute (NHLBI). Five clinical centers and a data-coordinating center were selected to participate in this research network. The CARE Network is conducting several studies for children with asthma and they have been sharing their findings with the health care community.

Problem

Children with mild asthma are often prescribed daily-inhaled corticosteroids (ICS), however, it is not clear how long these children must continue to take these. Keeping children on daily doses of ICS when their asthma is under good control could be costly, both in terms of cost of medication as well as potential side effects and the extra burden daily doses place on parents and children. No systematic studies have addressed this issue.

Goal

Determine how to safely and systematically wean children off of ICS controllers after long periods of wellness.

Objectives

This study will collect empirical data on two questions about the treatment of childhood asthma:

  • What is the best strategy for discontinuing therapy in children with mild asthma who are under good control but still presumably at risk for exacerbations?
  • Is there a treatment regimen that will decrease the risk of exacerbations in children with mild disease to a higher extent than what is achieved today with?

Population

Served In Wisconsin, 56 children (age 6-17 years) with mild persistent asthma will be enrolled. Nationwide, 280 children will be enrolled in this study.

Timeline

Individual study participation lasts for 44 weeks; the study is slated to end in early 2009.

Funding Source(s)

  • National Institute of Health’s National Heart, Lung, and Blood Institute (NHLBI)
  • TEVA Pharmaceutical Industries Limited (medication)

Local Principal Investigators

  • Elizabeth Bade, M.D. Aurora UW Medical Group
  • Robert Lemanske, M.D. University of Wisconsin-Madison

For more information, contact:

Ruth Perez, B.A.
Project Coordinator
(414) 219-CARE (2273)
ruth.1.perez@aurora.org 

or visit the Care Network website:
http://www.asthma-carenet.org/

CARE Network Sites

Clinical Centers

  • Denver: National Jewish Medical & Research Center
  • Madison: University of Wisconsin
  • San Diego: University of California Kaiser Permanente California
  • St. Louis: Washington University
  • Tucson: University of Arizona

Satellite Centers

  • Albuquerque: University of New Mexico
  • Milwaukee: Center for Urban Population Health

Data Coordinating Center

  • Hershey: Penn State University

NIH Funding Agency

  • Bethesda, MD: National Heart, Lung, and Blood Institute

Care Network Organizational Information

Administratively, the main governing body of the network is its Steering Committee. The Steering Committee consists of the Principal Investigator from each Clinical Center, the Principal Investigator from the Data Coordinating Center, a Chairman who is not an Investigator, and a Project Scientist from the NHLBI.

Our Address

Center for Urban Population Health 1020 North 12th Street, Suite 4180, Milwaukee, WI 53233 414-219-5100 (Phone) 414-219-6563 (Fax)

Our Partners

  • University of Wisconsin School of Medicine and Public Health
  • University of Wisconsin–Milwaukee
  • Aurora Health Care